Enzymatica AB (publ) (STO:ENZY)
2.570
-0.010 (-0.39%)
Aug 15, 2025, 5:24 PM CET
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 623.83 million as of August 15, 2025. Its market cap has increased by 72.98% in one year.
Market Cap
623.83M
Enterprise Value
580.13M
Revenue
50.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.57
Market Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 623.83M, an increase of 472.70%. That is a compound annual growth rate of 13.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 623.83M | 82.99% |
Dec 30, 2024 | 340.92M | -47.39% |
Dec 29, 2023 | 647.99M | -12.33% |
Dec 30, 2022 | 739.16M | -43.36% |
Dec 30, 2021 | 1.31B | -51.13% |
Dec 30, 2020 | 2.67B | 371.03% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 94.91B |
Sectra AB | 66.63B |
Getinge AB | 54.96B |
Medicover AB | 41.37B |
Camurus AB | 38.68B |
Asker Healthcare Group AB | 38.05B |
BioArctic AB | 20.66B |
AddLife AB | 20.16B |